Reported by Dong-A Ilbo / Aug 14, 2024.
‘SOMNUM Medella’ Finds Sleep Rhythm for Patients
Reflects 4 Indicators Including Lifestyle, Sleep, and Medication Use
Enhances Compliance and Shows Improvement in Insomnia Over One Month of Clinical Trials
HoneyNaps and Professor Jeong Seok-hoon of Asan Medical Center Collaborate on 'SOMNUM Medella'. Provided by HoneyNaps
"Is Not Being Able to Sleep Really a Problem?"
During the first HoneyNaps Sleep Symposium held on August 10, Professor Jeong Seok-hoon, a specialist in psychiatry at Asan Medical Center, stated, "The anxiety surrounding insomnia often leads to more significant sleep disorders than the inability to fall asleep itself."
Historically, the sleep industry focused on pharmaceuticals, medical devices, and bedding for the diagnosis and treatment of sleep disorders. However, with the rise of digital healthcare, "SleepTech," which utilizes ICT (Information and Communication Technology) to address sleep issues in daily life, is gaining traction.
While various applications aimed at sleep management are emerging, low patient compliance remains a challenge.
To enhance user adherence, Jeong and HoneyNaps integrated a digital therapeutic application (dSIBT-I) into their 'SOMNUM Medella,' which reflects the four sleep indicators.
The first indicator assesses daytime activity versus nighttime sleep. Professor Jeong stresses the need to shift perspectives on sleep; achieving seven hours of quality sleep requires 17 hours of activity during the day.
Secondly, improving sleep efficiency is crucial; if one plans to sleep for five hours, they should only lie down for five hours. Oversleeping or going to bed early to compensate for lost sleep can perpetuate insomnia. Increasing the time spent on bed worrying about sleep can reduce actual sleep efficiency, suggesting that individuals should only lie down when they are truly ready to sleep. If restlessness persists, it may be better to get out of bed.
The third indicator highlights the importance of reducing daytime lying down. Lying down during the day is akin to sleeping, which can hinder nighttime rest. Engaging in seated activities or light walks is encouraged. If one feels tired, short naps are acceptable, but should not exceed 30 minutes.
Finally, the timing of sleep aids or sedatives should be determined by wake-up times rather than sleep times. Taking sleep medication too early in anticipation of sleeplessness can diminish its effectiveness.
HoneyNaps has announced clinical trial results evaluating the efficacy and safety of their ‘Sleep Indicator-Based Cognitive Behavioral Therapy for Insomnia Digital Therapeutic.’
The trial was conducted as a randomized, prospective, double-blind study comparing the digital therapeutic application (dSIBT-I) with traditional Cognitive Behavioral Therapy for Insomnia (CBT-I) to evaluate the efficacy and safety of digital therapeutic application.
Fifty insomnia patients were randomly assigned to the dSIBT-I group, with both groups evaluated on sleep indicators over a month. Both groups showed improvements in the Insomnia Severity Index (ISI) scores, and no significant differences were noted in the treatment processes. Notably, the dSIBT-I group exhibited even better results than the CBT-I group by the second week.
Comments